Health utility values associated with diabetic retinopathy

Diabetic Medicine

Volumn 25, Issue 5, 2008, Pages 618-624

  Lloyd, A ^a   Nafees, B ^a   Gavriel, S ^a   Rousculp, M D ^b   Boye, K S ^b   Ahmad, A ^c  

^a ICON PLC   (United Kingdom)

^b ELI LILLY AND COMPANY   (United States)

^c ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Diabetic retinopathy; Quality of life; Utility; Visual function

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HEALTH CARE UTILIZATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; QUALITY OF LIFE; SCORING SYSTEM; STRUCTURED INTERVIEW; STRUCTURED QUESTIONNAIRE; UNITED KINGDOM; VISUAL ACUITY; VISUAL IMPAIRMENT;

ATTITUDE TO HEALTH; DIABETIC RETINOPATHY; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; SICKNESS IMPACT PROFILE; VISUAL ACUITY;

EID: 42549093519     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2008.02430.x     Document Type: Article

References (25)

1. Watkins PJ. ABC of diabetes. Retinopathy BMJ 2003 326 : 924 926.
2. Brown MM, Brown GC, Sharma S, Shaw G. Utility values and diabetic retinopathy. Am J Ophthalmol 1999 128 : 324 330.
3. Brown MM, Brown GC, Sharma S, Busbee B. Quality of life associated with visual loss - a time tradeoff utility analysis comparison with medical health states. Ophthalmology 2003 110 : 1076 1081.
4. Woodcock A, Bradley C, Plowright R. The influence of diabetic retinopathy on quality of life. Interviews to guide the design of a condition-specific, individualised questionnaire: the RetDQoL. Patient Educ Couns 2004 53 : 365 383.
5. Sharma S, Oliver-Fernandez A, Bakal J, Hollands H, Brown GC, Brown MM. Utilities associated with diabetic retinopathy: results from a Canadian sample. Br J Ophthalmol 2003 87 : 259 261.
6. Clarke P, Gray A, Legood R, Briggs A, Holman R. The impact of diabetes-related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65). Diabet Med 2003 20 : 442 450.
7. Klein R, Sharrett AR, Klein BE, Moss SE, Folsom AR, Wong TY et al. The association of atherosclerosis, vascular risk factors and retinopathy in adults with diabetes: the Atherosclerosis Risk in Communities Study. Ophthalmology 2002 109 : 1225 1234.
8. Clarke P, Gray A, Holman A. Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62). Med Decis Making 2002 22 : 340 349.
9. Clarke P, Simon J, Cull CA, Holman R. Assessing the impact of visual acuity on quality of life in individuals with type 2 diabetes using the Short Form-36. Diabetes Care 2006 29 : 1506 1511.
10. Shah VA, Gupta SK, Shah KV, Vinjamaram S, Chalam KV. TTO utility scores measure quality of life in patients with visual morbidity due to diabetic retinopathy or ARMD. Ophthalmic Epidemiol 2004 11 : 43 51.
11. Abballéa S, Tsuchiya A. Seeing for yourself: feasibility study towards valuing visual impairment using simulation spectacles. Health Econ 2007 16 : 537 543.
12. Coffey JT, Brandle M, Zhou H, Marriott D, Burke R, Tabaei BP et al. Valuing health-related quality of life in diabetes. Diabetes Care 2002 25 : 2238 2243.
13. Bagust A, Beale S. Modelling EuroQol related health-related utility values for diabetic complications from CODE-2 data. Health Econ 2005 14 : 217 230.
14. Coyne KS, Margolis MK, Kennedy-Martin K, Baker TM, Klein R, Paul MD et al. The impact of diabetic retinopathy: perspectives from patient focus groups. Fam Pract 2004 21 : 447 453.
15. Woodcock AJ, Bradley C, Plowright R. Patient experiences of treatment for diabetic retinopathy: development of a retinopathy-specific treatment satisfaction questionnaire. Diabet Med 2003 19 : 10.
16. Kind P, Dolan P, Gudex C, Williams A. Variations in population health status: results from a United Kingdom national questionnaire survey. BMJ 1998 316 : 736 741.
17. Torrance GW. Utility approach to measuring health-related quality of life. J Chronic Disord 1987 40 : 593 603.
18. Bennett KJ, Torrance GW. Measuring health state preferences and utilities: rating scale, time trade-off, and standard gamble techniques. In Spilker B ed. Quality of Life and Pharmacoeconomics in Clinical Trials. Philadelphia, PA : Lippincott-Raven Publishers, 1996.
19. Wexler DJ, Grant RW, Wittenberg E. Correlates of health-related quality of life in type 2 diabetes. Diabetologia 2006 49 : 1489 1497.
20. Holladay JT. Visual acuity measurements. J Cataract Refract Surg 2004 30 : 287 290.
21. Gold M, Franks P, Erickson P. Assessing the health of the nation. The predictive validity of a preference-based measure and self-rated health. Med Care 1996 34 : 163 177.
22. Chakravorty I, Cayton RM, Szczepura A. Health utilities in evaluating intervention in the sleep apnoea/hypopnoea syndrome. Eur Respir J 2002 20 : 1233 1238.
23. Matza LS, Secnik K, Rentz AM, Mannix S, Sallee FR, Gilbert D et al. Assessment of health state utilities for attention-deficit/hyperactivity disorder in children using parent proxy report. Qual Life Res 2005 14 : 735 747.
24. Singer LG, Gould MK, Tomlinson G, Theodore J. Determinants of health utility in lung and heart-lung transplant recipients. Am J Transplant 2005 5 : 103 109.
25. Tavakoli M, Malek M. The cost utility analysis of riluzole for the treatment of amyotrophic lateral sclerosis in the UK. J Neurol Sci 2001 191 : 95 102.